These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1363996)

  • 1. [The role of the brain dopaminergic mechanisms in different models of anxiety states].
    Talalaenko AN; Abramets II; Stakhovskiĭ IuV; Shekhovtsov AA; Chernikov AV; Shevchenko SL
    Fiziol Zh Im I M Sechenova; 1992 Dec; 78(12):70-7. PubMed ID: 1363996
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current developments in the pharmacology of dopaminergic receptors (II)].
    Nechifor M
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(2):393-4. PubMed ID: 2573123
    [No Abstract]   [Full Text] [Related]  

  • 3. [The realization of a conditioned avoidance reflex in rats under conditions of the multiple activation of the globus pallidus dopaminergic system].
    Iakimskiĭ AF
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1998; 48(1):47-53. PubMed ID: 9583163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of neurochemical mechanisms of ventromedial hypothalamus in various models of anxiety in rats.
    Talalaenko AN; Gordienko DV; Pankrat'ev DV; Zinkovich II; Krivobok GK
    Bull Exp Biol Med; 2001 Jan; 131(1):38-40. PubMed ID: 11329078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The administration of fenamine into the rostral and caudal sections of the rat neostriatum disturbs the realization of conditioned reflex escape behavior].
    Iakimovskiĭ AF; Ryzhova KV
    Ross Fiziol Zh Im I M Sechenova; 1997 Aug; 83(8):33-8. PubMed ID: 9487047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: Structural and functional analysis.
    de la Mora MP; Gallegos-Cari A; Arizmendi-García Y; Marcellino D; Fuxe K
    Prog Neurobiol; 2010 Feb; 90(2):198-216. PubMed ID: 19853006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The morphochemical characteristics of the reaction of the motor structures of the brain to hyper- and hypofunction of the dopaminergic system].
    Gershteĭn LM; Dovedova EL; Dobrynina MT; Sergutina AV; Rakhmanova VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(6):49-53. PubMed ID: 9072895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dysthymic disorders and dopaminergic drugs].
    Schmitt L; Olivier F; Fournié-DeJean I
    Encephale; 1992 Dec; 18 Spec No 5():755-9. PubMed ID: 1364157
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current developments in the pharmacology of dopaminergic receptors (I)].
    Nechifor M; Lucaci L
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(1):143-4. PubMed ID: 2573121
    [No Abstract]   [Full Text] [Related]  

  • 10. High and abnormal forms of aggression in rats with extremes in trait anxiety--involvement of the dopamine system in the nucleus accumbens.
    Beiderbeck DI; Reber SO; Havasi A; Bredewold R; Veenema AH; Neumann ID
    Psychoneuroendocrinology; 2012 Dec; 37(12):1969-80. PubMed ID: 22608548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Brain dopamine receptors. Interactions between D1 and D2 receptors, and dopamine mediated behaviour].
    Costentin J
    Therapie; 1991; 46(4):269-82. PubMed ID: 1683022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current developments in the pharmacology of the dopaminergic receptors. III].
    Nechifor M; Lucaci L
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(3):510, 516, 566. PubMed ID: 2576889
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine receptor agonists and antagonists.
    Kohli JD
    Proc West Pharmacol Soc; 1990; 33():21-7. PubMed ID: 1980362
    [No Abstract]   [Full Text] [Related]  

  • 14. [Functional role and pharmacological regulation of the dopaminergic system of the brain].
    Raevskiĭ KS
    Vestn Ross Akad Med Nauk; 1998; (8):19-24. PubMed ID: 9771125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of D1 and D2 receptors in the regulation of intraocular pressure.
    Spampinato D; Cavaliere S; Dal Bello A; Caruso P; Marino V; Drago F
    Pharmacol Res; 1990; 22 Suppl 1():57-8. PubMed ID: 1980948
    [No Abstract]   [Full Text] [Related]  

  • 16. [Action sites of morphine--effects on dopaminergic and GABA-containing neurons in the basal ganglia].
    Kondo Y
    Osaka Daigaku Shigaku Zasshi; 1980 Jun; 25(1):15-28. PubMed ID: 6256512
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of selective dopamine D-1 and D-2 antagonists on the locomotor response and brain monoamine changes induced by naloxone-precipitated morphine withdrawal in guinea pigs.
    Brent PJ; Chahl LA
    Prog Clin Biol Res; 1990; 328():515-8. PubMed ID: 2406762
    [No Abstract]   [Full Text] [Related]  

  • 18. Peripheral dopaminergic nerves.
    Bell C
    Pharmacol Ther; 1989; 44(2):157-79. PubMed ID: 2577510
    [No Abstract]   [Full Text] [Related]  

  • 19. Altered open field behavior in rats induced by acute administration of 3-nitropropionic acid: possible glutamatergic and dopaminergic involvement.
    Lukács A; Szabó A; Papp A; Vezér T
    Acta Biol Hung; 2009 Dec; 60(4):359-67. PubMed ID: 20015828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The brain dopamine receptors in chronically alcoholized animals with different relationships to alcohol].
    Bondarenko TT; Vekshina NL
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(1):168-71. PubMed ID: 1316008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.